$AGIO Headlines Four signs that would indicate a new

New Post Public Reply Private Reply Replies (0) Message Board

Jan 18, 2015 at 10:50 AM

$AGIO Headlines

Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin

A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 1:00 a.m. Jan. 13, 2015 - Zacks.com
Value Investing Strategy For Biotech 12:57 p.m. Jan. 12, 2015 - Seeking Alpha
New Lifetime High Reached: Agios Pharmaceuticals (AGIO) 9:45 a.m. Jan. 12, 2015 - TheStreet.com
Why Agios Pharmaceuticals (AGIO) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. Jan. 12, 2015 - Zacks.com
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 10:37 a.m. Jan. 8, 2015 - Seeking Alpha
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
Jim Cramer: Why Are You Shorting Innovative Biotech Stocks? 11:37 a.m. Jan. 6, 2015 - TheStreet.com
Biotech Stocks 2014: The Best, Worst and Fastest-Growing 8:33 a.m. Jan. 2, 2015 - TheStreet.com
Bull of the Day: Incyte (INCY) - Bull of the Day 1:00 a.m. Jan. 2, 2015 - Zacks.com
Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens 6:00 a.m. Dec. 29, 2014 - TheStreet.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's "Dead Cat Bounce" Stock 9:57 a.m. Dec. 24, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Tanks 13.6% - Tale of the Tape 8:48 a.m. Dec. 24, 2014 - Zacks.com
Agios Pharmaceuticals (AGIO) Is Today's Water-Logged And Getting Wetter Stock 12:33 p.m. Dec. 23, 2014 - TheStreet.com
Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger? 11:21 a.m. Dec. 23, 2014 - Seeking Alpha
3 Stocks With Plunging Prices 11:00 a.m. Dec. 23, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up 12/18/14: Agios Pharmaceuticals, Inc.,Unit Corporation, China Cord Blood Corporation, Saba Software, Inc. 10:49 a.m. Dec. 19, 2014 - Seeking Alpha
Insider Trading Alert - USCR, AGIO And CVV Traded By Insiders 10:06 a.m. Dec. 19, 2014 - TheStreet.com

Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration 9:24 p.m. Jan. 12, 2015 - GlobeNewswire
Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 4:06 p.m. Jan. 5, 2015 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock 8:42 p.m. Dec. 10, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Proposed Offering of Common Stock 4:23 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors 4:02 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency 1:01 p.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016 7:31 a.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Nov. 20, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurzen Leverages Basquiat for Art-Infused Projection Line

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Lennar Unveils Lake Martin Community Homes

Lake Martin's New Residential Offering Step aside, beaches and mountains. Now it's all about lakeside living with some good old Alabama charm. Lennar, a heavyweight in the homebuilding scene, is opening the gates to The Oaks at Eclectic—a fresh batch of single-family homes sprouting near Lake Martin in Eclectic, Alabama. This spot is practically a haven for those who...

Lupin Gains FDA Nod for Modafinil, Eyes US Market

In the ever-evolving landscape of pharmaceuticals, Lupin Limited's recent triumph snagging FDA approval for their Modafinil Tablets was a move you couldn't miss even if you'd tried. While the rooms of Mumbai and boardrooms around the globe might have been abuzz, investors should tune in to the humming potential of this development—especially if they're navigating the...

AI Data Retention: FastGPT’s Detailed Deletion Protocols

In the world of AI-driven applications, data retention has become a hot potato, especially when we're talking about sensitive information like conversation records and audit logs. FastGPT, an open-source AI platform, has decided to tell it like it is by detailing exactly how these data pieces are retained and ultimately booted out. All this info was scattered to the winds...

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

TriStar Bank Community Room: A Space for Growth

Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...

Fujifilm's New 400mm Lens: A Game Changer?

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

New Concierge Pediatric Care at Weill Cornell Launches

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Inturai Ventures Closes Final Tranche with a Twist

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...